AQR Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $61.3M | Sell |
188,249
-640,095
| -77% | -$208M | 0.05% | 484 |
|
2025
Q1 | $217M | Buy |
828,344
+14,988
| +2% | +$3.93M | 0.22% | 101 |
|
2024
Q4 | $191M | Buy |
813,356
+307,702
| +61% | +$72.4M | 0.25% | 76 |
|
2024
Q3 | $139M | Buy |
505,654
+234,035
| +86% | +$64.3M | 0.19% | 122 |
|
2024
Q2 | $65.9M | Buy |
271,619
+130,482
| +92% | +$31.6M | 0.1% | 246 |
|
2024
Q1 | $21.1M | Buy |
141,137
+127,117
| +907% | +$19M | 0.04% | 510 |
|
2023
Q4 | $2.68M | Buy |
14,020
+4,560
| +48% | +$873K | 0.01% | 1214 |
|
2023
Q3 | $1.66M | Buy |
9,460
+3,726
| +65% | +$655K | ﹤0.01% | 1405 |
|
2023
Q2 | $1.09M | Sell |
5,734
-373
| -6% | -$70.8K | ﹤0.01% | 1517 |
|
2023
Q1 | $1.21M | Buy |
+6,107
| New | +$1.21M | ﹤0.01% | 1472 |
|
2022
Q4 | – | Sell |
-11,768
| Closed | -$2.36M | – | 2199 |
|
2022
Q3 | $2.36M | Buy |
11,768
+5,754
| +96% | +$1.15M | 0.01% | 1135 |
|
2022
Q2 | $865K | Sell |
6,014
-5,233
| -47% | -$753K | ﹤0.01% | 1478 |
|
2022
Q1 | $1.84M | Buy |
11,247
+9,123
| +430% | +$1.49M | ﹤0.01% | 1229 |
|
2021
Q4 | $360K | Buy |
+2,124
| New | +$360K | ﹤0.01% | 1928 |
|
2021
Q2 | – | Sell |
-1,914
| Closed | -$269K | – | 2218 |
|
2021
Q1 | $269K | Sell |
1,914
-37,733
| -95% | -$5.3M | ﹤0.01% | 2041 |
|
2020
Q4 | $5.1M | Sell |
39,647
-32,134
| -45% | -$4.13M | 0.01% | 783 |
|
2020
Q3 | $10.3M | Sell |
71,781
-23,400
| -25% | -$3.37M | 0.02% | 623 |
|
2020
Q2 | $14.1M | Buy |
95,181
+48,963
| +106% | +$7.25M | 0.02% | 553 |
|
2020
Q1 | $5.03M | Buy |
+46,218
| New | +$5.03M | 0.01% | 771 |
|
2019
Q2 | – | Sell |
-2,367
| Closed | -$221K | – | 2059 |
|
2019
Q1 | $221K | Buy |
+2,367
| New | +$221K | ﹤0.01% | 2044 |
|
2018
Q4 | – | Sell |
-9,638
| Closed | -$844K | – | 2180 |
|
2018
Q3 | $844K | Sell |
9,638
-4,249
| -31% | -$372K | ﹤0.01% | 1764 |
|
2018
Q2 | $1.37M | Sell |
13,887
-334
| -2% | -$32.9K | ﹤0.01% | 1592 |
|
2018
Q1 | $1.69M | Buy |
14,221
+7,676
| +117% | +$914K | ﹤0.01% | 1435 |
|
2017
Q4 | $832K | Buy |
+6,545
| New | +$832K | ﹤0.01% | 1735 |
|
2017
Q1 | – | Sell |
-27,669
| Closed | -$1.04M | – | 2170 |
|
2016
Q4 | $1.04M | Buy |
+27,669
| New | +$1.04M | ﹤0.01% | 1679 |
|
2016
Q2 | – | Sell |
-3,739
| Closed | -$235K | – | 2193 |
|
2016
Q1 | $235K | Sell |
3,739
-212,939
| -98% | -$13.4M | ﹤0.01% | 2069 |
|
2015
Q4 | $20.4M | Buy |
216,678
+62,887
| +41% | +$5.92M | 0.04% | 544 |
|
2015
Q3 | $12.4M | Buy |
153,791
+71,679
| +87% | +$5.76M | 0.02% | 575 |
|
2015
Q2 | $9.84M | Buy |
82,112
+34,764
| +73% | +$4.17M | 0.02% | 614 |
|
2015
Q1 | $4.94M | Buy |
47,348
+28,979
| +158% | +$3.03M | 0.01% | 783 |
|
2014
Q4 | $1.78M | Sell |
18,369
-11,900
| -39% | -$1.15M | ﹤0.01% | 1349 |
|
2014
Q3 | $2.36M | Buy |
30,269
+2,264
| +8% | +$177K | 0.01% | 1176 |
|
2014
Q2 | $1.77M | Buy |
28,005
+6,800
| +32% | +$430K | ﹤0.01% | 1357 |
|
2014
Q1 | $1.42M | Sell |
21,205
-2,200
| -9% | -$148K | ﹤0.01% | 1504 |
|
2013
Q4 | $1.51M | Sell |
23,405
-20,878
| -47% | -$1.34M | ﹤0.01% | 1518 |
|
2013
Q3 | $2.84M | Sell |
44,283
-211
| -0.5% | -$13.5K | 0.01% | 1082 |
|
2013
Q2 | $1.38M | Buy |
+44,494
| New | +$1.38M | ﹤0.01% | 1408 |
|